Overview
The problem of the inflammatory disorders such as rheumatoid arthritis and osteoarthritis are not unique to the developing countries but are rather global. Majority of the chronic inflammatory disorders are difficult to treat. After consuming the existing drugs such as NSAIDs and corticosteroids in particular, patients often suffer from drug related unknown side effects and toxicity that is worse than the primary disease.The main aim of inflammation pharmacology in IIIM is to evaluate and identify the natural, semi-synthetic or synthetic molecules isolated from the botanicals or synthesized for their anti-inflammatory/ anti-arthritic potential. These molecules are screened through a battery of
in-vitro and
in-vivo assay models to identify them to be better than the existing molecules in the market for the human use.
Mission and goals